Annual General Shareholders’ Meeting 2023 – June 16, 2023 - 2nd call – Expected to be held on this date / June 15, 2023 - 1st call. Click here.

NEWSROOM

179 results have been found

Company statement
Press release

Corporate
Investors
Products
Sustainability

2023
2022
2021
2020
2019

Order by: Newest A-Z

June 8, 2023

Grifols Group enters into agreement with Canadian Plasma Resources to secure plasma supply in Canada

Read Release

June 7, 2023

Grifols Egypt delivers first plasma medicines made from Egyptian plasma donations

Read Release

May 11, 2023

Grifols launches AlphaID™ At Home, enabling U.S. consumers to self-screen for genetic COPD

Read Release

May 9, 2023

Grifols delivers strong first quarter financials with 23% revenue growth and an Adjusted EBITDA margin above guidance of 21%

Read Release

May 8, 2023

Grifols realigns management structure to accelerate company performance and simplify its corporate governance

Read Release

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.